Human medicines European public assessment report (EPAR): Tepkinly, epcoritamab, Date of authorisation: 22/09/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Ozawade, pitolisant, Date of authorisation: 01/09/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Deqtynet, copper (64Cu) oxodotreotide, Date of refusal: 03/08/2026, Status: Refused

Minutes - Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - July 2026

Fees payable to the European Medicines Agency: Guidance for all applicants

Human medicines European public assessment report (EPAR): Wakix, pitolisant, Date of authorisation: 31/03/2016, Revision: 20, Status: Authorised

Desogestrel / etonogestrel

PSUSA/00000736/202509

PSUSA/00000669/202512

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of authorisation: 29/09/2023, Revision: 1, Status: Authorised